The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Treprostinil Drugs Market Outlook 2024

Global Treprostinil Drugs Market Outlook 2024

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1665153

No of Pages : 94

Synopsis
Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension.
North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8%.

The global Treprostinil Drugs market was valued at US$ 1237.7 million in 2020 and is expected to reach US$ 1299.6 million by the end of 2027, growing at a CAGR of 0.7% during 2021-2027.
This report focuses on Treprostinil Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Treprostinil Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Treprostinil Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Remodulin
Tyvaso
Orenitram

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
United Therapeutics
Novartis
Teva
Index
1 Treprostinil Drugs Market Overview
1.1 Product Overview and Scope of Treprostinil Drugs
1.2 Treprostinil Drugs Segment by Type
1.2.1 Global Treprostinil Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Remodulin
1.2.3 Tyvaso
1.2.4 Orenitram
1.3 Treprostinil Drugs Segment by Application
1.3.1 Global Treprostinil Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Treprostinil Drugs Market Size Estimates and Forecasts
1.4.1 Global Treprostinil Drugs Revenue 2016-2027
1.4.2 Global Treprostinil Drugs Sales 2016-2027
1.4.3 Treprostinil Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Treprostinil Drugs Market Competition by Manufacturers
2.1 Global Treprostinil Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Treprostinil Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Treprostinil Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Treprostinil Drugs Manufacturing Sites, Area Served, Product Type
2.5 Treprostinil Drugs Market Competitive Situation and Trends
2.5.1 Treprostinil Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Treprostinil Drugs Players Market Share by Revenue
2.5.3 Global Treprostinil Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Treprostinil Drugs Retrospective Market Scenario by Region
3.1 Global Treprostinil Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Treprostinil Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Treprostinil Drugs Market Facts & Figures by Country
3.3.1 North America Treprostinil Drugs Sales by Country
3.3.2 North America Treprostinil Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Treprostinil Drugs Market Facts & Figures by Country
3.4.1 Europe Treprostinil Drugs Sales by Country
3.4.2 Europe Treprostinil Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Treprostinil Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Treprostinil Drugs Sales by Region
3.5.2 Asia Pacific Treprostinil Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Treprostinil Drugs Market Facts & Figures by Country
3.6.1 Latin America Treprostinil Drugs Sales by Country
3.6.2 Latin America Treprostinil Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Treprostinil Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Treprostinil Drugs Sales by Country
3.7.2 Middle East and Africa Treprostinil Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Treprostinil Drugs Historic Market Analysis by Type
4.1 Global Treprostinil Drugs Sales Market Share by Type (2016-2021)
4.2 Global Treprostinil Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Treprostinil Drugs Price by Type (2016-2021)

5 Global Treprostinil Drugs Historic Market Analysis by Application
5.1 Global Treprostinil Drugs Sales Market Share by Application (2016-2021)
5.2 Global Treprostinil Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Treprostinil Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 United Therapeutics
6.1.1 United Therapeutics Corporation Information
6.1.2 United Therapeutics Description and Business Overview
6.1.3 United Therapeutics Treprostinil Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 United Therapeutics Treprostinil Drugs Product Portfolio
6.1.5 United Therapeutics Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Treprostinil Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Treprostinil Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Treprostinil Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Treprostinil Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates

7 Treprostinil Drugs Manufacturing Cost Analysis
7.1 Treprostinil Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Treprostinil Drugs
7.4 Treprostinil Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Treprostinil Drugs Distributors List
8.3 Treprostinil Drugs Customers

9 Treprostinil Drugs Market Dynamics
9.1 Treprostinil Drugs Industry Trends
9.2 Treprostinil Drugs Growth Drivers
9.3 Treprostinil Drugs Market Challenges
9.4 Treprostinil Drugs Market Restraints

10 Global Market Forecast
10.1 Treprostinil Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Treprostinil Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Treprostinil Drugs by Type (2022-2027)
10.2 Treprostinil Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Treprostinil Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Treprostinil Drugs by Application (2022-2027)
10.3 Treprostinil Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Treprostinil Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Treprostinil Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Treprostinil Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Treprostinil Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Treprostinil Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Treprostinil Drugs Covered in This Study
Table 5. Global Treprostinil Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Treprostinil Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Treprostinil Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Treprostinil Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Treprostinil Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Treprostinil Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Treprostinil Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Treprostinil Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treprostinil Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Treprostinil Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Treprostinil Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Treprostinil Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Treprostinil Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Treprostinil Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Treprostinil Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Treprostinil Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Treprostinil Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Treprostinil Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Treprostinil Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Treprostinil Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Treprostinil Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Treprostinil Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Treprostinil Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Treprostinil Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Treprostinil Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Treprostinil Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Treprostinil Drugs Revenue Share by Type (2016-2021)
Table 42. Global Treprostinil Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Treprostinil Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Treprostinil Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Treprostinil Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Treprostinil Drugs Revenue Share by Application (2016-2021)
Table 47. Global Treprostinil Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. United Therapeutics Corporation Information
Table 49. United Therapeutics Description and Business Overview
Table 50. United Therapeutics Treprostinil Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. United Therapeutics Treprostinil Drugs Product
Table 52. United Therapeutics Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Treprostinil Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Treprostinil Drugs Product
Table 57. Novartis Recent Developments/Updates
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Treprostinil Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Teva Treprostinil Drugs Product
Table 62. Teva Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Treprostinil Drugs Distributors List
Table 66. Treprostinil Drugs Customers List
Table 67. Treprostinil Drugs Market Trends
Table 68. Treprostinil Drugs Growth Drivers
Table 69. Treprostinil Drugs Market Challenges
Table 70. Treprostinil Drugs Market Restraints
Table 71. Global Treprostinil Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 72. Global Treprostinil Drugs Sales Market Share Forecast by Type (2022-2027)
Table 73. Global Treprostinil Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global Treprostinil Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global Treprostinil Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 76. Global Treprostinil Drugs Sales Market Share Forecast by Application (2022-2027)
Table 77. Global Treprostinil Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global Treprostinil Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global Treprostinil Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 80. Global Treprostinil Drugs Sales Market Share Forecast by Region (2022-2027)
Table 81. Global Treprostinil Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global Treprostinil Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Treprostinil Drugs
Figure 2. Global Treprostinil Drugs Market Share by Type in 2020 & 2027
Figure 3. Remodulin Product Picture
Figure 4. Tyvaso Product Picture
Figure 5. Orenitram Product Picture
Figure 6. Global Treprostinil Drugs Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Global Treprostinil Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Treprostinil Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Treprostinil Drugs Sales 2016-2027 (K Units)
Figure 12. Global Treprostinil Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Treprostinil Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Treprostinil Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Treprostinil Drugs Players: Market Share by Revenue in 2020
Figure 16. Treprostinil Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Treprostinil Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Treprostinil Drugs Sales Market Share by Region in 2020
Figure 19. Global Treprostinil Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Treprostinil Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Treprostinil Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Treprostinil Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Treprostinil Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Treprostinil Drugs by Application in 2020
Figure 48. Revenue Share of Treprostinil Drugs by Application (2016-2021)
Figure 49. Revenue Share of Treprostinil Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Treprostinil Drugs
Figure 51. Manufacturing Process Analysis of Treprostinil Drugs
Figure 52. Treprostinil Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’